method for treating egfr-tki resistant non-small cell lung cancer by administering the anti-her3-drug antibody conjugate

摘要

to provide a therapeutic agent and therapeutic method for egfr-tki resistant non-small cell lung cancer. provided: a therapeutic agent that contains an anti-her3-drug antibody conjugate as an active ingredient, or a therapeutic method characterized by the administration of an anti-her3-drug antibody conjugate.